Current studies into retatritide peptide reveal notable possibility for addressing excess body and type 2 diabetes mellitus. The peptide, a dual activator of GLP-1 and GIP receptor, looks to provide greater weight reduction and glucose regulation compared existing medications. Ongoing patient stu